EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

International perspectives on AI-driven pharmaceutical IP challenges

Grace Y Wang, Jian-Ming Hao, Joe G Chen

Frontiers in Digital Health · 22.06.2026 · 8

DOI: 10.3389/fdgth.2026.1774406 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Digital Health, online erschienen am 22.06.2026. Verfasst von Grace Y Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: West Windsor High School-North, West Windsor, NJ, United States. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Artificial Intelligence (AI) is transforming the pharmaceutical sector by optimizing care delivery and accelerating drug design. While AI introduces significant benefits, it presents complex challenges regarding intellectual property (IP) frameworks. This review examines AI-driven innovations in personalized medicine and drug design, with a specific focus on inventorship issues that directly affect pharmaceutical patent protection. We analyze recent United States (US) legal developments concerning AI inventorship, including the US Supreme Court's March 2026 denial of certiorari in Thaler v. Perlmutter, which definitively resolved the question of AI inventorship under US law, provide comparative analyses of approaches in Germany and China, and identify specific lessons, rather than wholesale reforms, that may help stakeholders navigate the evolving intersection of AI and pharmaceutical IP.

Schlagwörter

Stichwörter der Autor:innen

artificial intelligencecopyrightdrug discoveryintellectual propertyinternational perspectiveinventorshippatent lawpersonalized medicine

Autor:innen und Institutionen

  • West Windsor High School-North, West Windsor, NJ, United States.
  • Intellectual Property Department, Fox Rothschild LLP, Princeton, NJ, United States.

Zitieren

APA

Wang, G. Y., Hao, J. M., & Chen, J. G. (2026). International perspectives on AI-driven pharmaceutical IP challenges. Frontiers in Digital Health, 8. https://doi.org/10.3389/fdgth.2026.1774406

Vancouver

Wang GY, Hao JM, Chen JG. International perspectives on AI-driven pharmaceutical IP challenges. Frontiers in Digital Health. 2026;8. doi:10.3389/fdgth.2026.1774406

BibTeX
@article{Wang2026,
  author = {Wang, Grace Y and Hao, Jian-Ming and Chen, Joe G},
  title = {International perspectives on AI-driven pharmaceutical IP challenges},
  journal = {Frontiers in Digital Health},
  year = {2026},
  volume = {8},
  doi = {10.3389/fdgth.2026.1774406}
}
Kostenlos starten →